~~<i id='3B98DD1D11'><strike id='3B98DD1D11'><tt id='3B98DD1D11'><pre id='3B98DD1D11'></pre></tt></strike></i>~~

Home» explore» explore

explore

author：comprehensive 2025-10-02 03:32:14 Page View：59

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virtual Event: March of the Biosimilars
Next article： Continuity nursing helped my family in our darkest PICU moments

Wikipedia

Drug repurposing or repositioning? The language matters

AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

Baby aspirin cuts fat buildup in liver disease patients, in small study

PatrickSison/APLow-doseaspirinledtoareductioninliverfatamongpatientswithmetabolic-associatedliverdis

Medical leaders decry Supreme Court decision on affirmative action

STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

Tori Bowie and the unacceptable rates of Black maternal death

AlastairGrant/APThehorrorstoriesofBlackwomendyingorcomingclosetodeathinchildbirthneverseemtostopcomi